Related Experiment Video

Updated: Mar 17, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

7.1K

Decreased miR-124-3p Expression Prompted Breast Cancer Cell Progression Mainly by Targeting Beclin-1

Fengfeng Zhang, Binbin Wang, Houlong Long

    Clinical Laboratory
    |July 30, 2016
    PubMed
    Abstract

    Insights

    MicroRNA-124-3p (miR-124-3p) is decreased in breast cancer, promoting cell progression by increasing Beclin-1 and autophagy. Restoring miR-124-3p levels may offer therapeutic potential.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Gene Regulation

    Background:

    • Aberrant microRNA (miRNA) expression is linked to cancer development.
    • This study identifies a novel miRNA regulating Beclin-1 in breast cancer.

    Purpose of the Study:

    • To investigate the role of miR-124-3p in breast cancer.
    • To determine if Beclin-1 is a target gene of miR-124-3p.

    Main Methods:

    • Expression analysis of miR-124-3p and Beclin-1 in breast cancer tissues and cell lines.
    • Luciferase reporter assay to confirm Beclin-1 as a miR-124-3p target.
    • Western blot and qRT-PCR to assess autophagy-related protein expression.

    Main Results:

    • miR-124-3p expression is significantly decreased in breast cancer.
    • miR-124-3p negatively regulates Beclin-1 expression.
    • Overexpression of miR-124-3p reduces Beclin-1 and LC3II levels, partially reversing 4-OHT-induced autophagy.

    Conclusions:

    • Downregulation of miR-124-3p promotes breast cancer progression.
    • This progression is mediated by enhanced expression of the autophagy protein Beclin-1.
    • miR-124-3p acts as a tumor suppressor in breast cancer by inhibiting autophagy.

    More Related Videos

    Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

    Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

    Published on: March 30, 2019

    8.1K
    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

    Published on: August 23, 2019

    7.8K

    Related Concept Videos

    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
    24.5K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    4.2K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.4K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    5.0K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    6.1K